n,n',n''-tris(2,3-dihydroxy-5-sulfobenzoyl)-1,5,10-triazadecane has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, P; Chen, J; Gilkes, DM; Korangath, P; Krishnamachary, B; Mitzner, WA; Raman, V; Schito, L; Semenza, GL; Sukumar, S; Wei, H; Winnard, PT; Wong, CC; Zhang, H; Zhen, L | 1 |
1 other study(ies) available for n,n',n''-tris(2,3-dihydroxy-5-sulfobenzoyl)-1,5,10-triazadecane and Breast Neoplasms
| Article | Year |
|---|---|
HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.
Topics: Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Angiopoietins; Animals; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Female; Humans; Hypoxia-Inducible Factor 1; Lung Neoplasms; Mice; Neoplasm Transplantation; RNA Interference; Spermidine | 2012 |